Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcin.2021.05.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Breaking boundaries: Ticagrelor monotherapy in high-risk patients.
Int J Cardiol Heart Vasc
December 2024
Medical Affairs, AstraZeneca Pharma India Ltd, India.
Atherosclerotic plaque formation is a leading cause of arterial thrombosis that significantly impacts global health by instigating major adverse cardiovascular events (MACE) like myocardial infarction (MI) and stroke. Platelets are central to this process, leading to the development of antiplatelet therapies, to mitigate MACE risks. The combination of aspirin with a potent P2Y inhibitor known as dual antiplatelet therapy (DAPT) is the standard for post-percutaneous coronary intervention (PCI) aimed at reducing ischemic events.
View Article and Find Full Text PDFGenotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves East.
JACC Cardiovasc Interv
April 2023
Department of Medicine, Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, USA.
Bilateral multifocal muscular hemorrhage in the triceps surae during antiplatelet therapy: a case report.
J Int Med Res
December 2021
Department of Physical Medicine & Rehabilitation, 90158Jeonbuk National University Medical School, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Hemorrhagic complications are often reported following antiplatelet therapy; however, simultaneous multifocal hemorrhages in both legs are uncommon. The patient was a 75-year-old man diagnosed with ST elevation myocardial infarction who underwent percutaneous coronary intervention in the right coronary artery. He was prescribed oral acetylsalicylic acid and ticagrelor.
View Article and Find Full Text PDFMoving Toward Ticagrelor Monotherapy: Like Boats Against the Current.
JACC Cardiovasc Interv
July 2021
AdventHealth Ocala, Ocala, Florida, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!